Pierre Fabre Taps XtalPi’s AI and Robotics for Drug Discovery
· unite.ai · popularity 15/100 · 0 similar stories today · Genetics, Genomics & Biotech (Science)
Read the original at unite.ai →
Summary
Laboratoires Pierre Fabre and XtalPi announced on November 9, 2026 an agreement to discover novel small-molecule clinical candidates across multiple research programs. XtalPi will contribute integrated AI capabilities and a robotics platform, while Pierre Fabre will select and advance compounds in oncology, potentially dermatology, and rare diseases. The partners are directing that work toward challenging and historically hard-to-drug targets, which they associate with significant unmet medical…
Found in: Unite.AI. Rating basis: single outlet; outlet tier 2 (unlisted); 1 feeds; feed position 20.